Document is current
Any future updates will be listed below
-
Authors
Genius, Patricia https://orcid.org/0000-0003-1836-5123
Fernández-Bonet, Alba
Rodríguez-Fernández, Blanca
Gallay, Clara
Gonzalez-Escalante, Armand
Sánchez-Benavides, Gonzalo
López-Martos, David
Esteller, Manel
Navarro, Arcadi
Gispert, Juan D.
Brugulat-Serrat, Anna
Vilor-Tejedor, Natalia https://orcid.org/0000-0003-4935-6721
,
-
Funding
Funding for this research was provided by:
Alzheimer's Association ((AACSF-23-1145154).)
Spanish Ministry of Science and Innovation - State Research Agency (RYC2022-038136-I)
William H. Gates Sr. Fellowship from the Alzheimer’s Disease Data Initiative (Cohort I)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 26 November 2025
First Online: 17 February 2026
Declarations
:
: The ALFA+ study (ALFA-FPM-0311) was approved by the Independent Ethics Committee ‘Parc de Salut Mar’, Barcelona and registered at Clinicaltrials.gov (Identifier: NCT02485730). All participating subjects signed the study’s informed consent form, which was approved by the Independent Ethics Committee ‘Parc de Salut Mar’, Barcelona. The study was conducted according to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
